CY1106973T1 - Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms) - Google Patents

Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)

Info

Publication number
CY1106973T1
CY1106973T1 CY20071101413T CY071101413T CY1106973T1 CY 1106973 T1 CY1106973 T1 CY 1106973T1 CY 20071101413 T CY20071101413 T CY 20071101413T CY 071101413 T CY071101413 T CY 071101413T CY 1106973 T1 CY1106973 T1 CY 1106973T1
Authority
CY
Cyprus
Prior art keywords
androgen
thaizolin
sarms
conductors
products
Prior art date
Application number
CY20071101413T
Other languages
Greek (el)
English (en)
Inventor
Raymond A Ng
Zhihua Sui
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1106973T1 publication Critical patent/CY1106973T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20071101413T 2003-06-13 2007-11-05 Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms) CY1106973T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47871203P 2003-06-13 2003-06-13
EP04755044A EP1656360B1 (en) 2003-06-13 2004-06-12 Thiazoline derivatives as selective androgen receptor modulators (sarms)

Publications (1)

Publication Number Publication Date
CY1106973T1 true CY1106973T1 (el) 2012-09-26

Family

ID=33539114

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101413T CY1106973T1 (el) 2003-06-13 2007-11-05 Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)

Country Status (14)

Country Link
US (1) US20050014952A1 (https=)
EP (1) EP1656360B1 (https=)
JP (1) JP4898446B2 (https=)
CN (1) CN1835937B (https=)
AT (1) ATE370133T1 (https=)
AU (1) AU2004249697B2 (https=)
CA (1) CA2528764A1 (https=)
CY (1) CY1106973T1 (https=)
DE (1) DE602004008300T2 (https=)
DK (1) DK1656360T3 (https=)
ES (1) ES2291906T3 (https=)
PL (1) PL1656360T3 (https=)
PT (1) PT1656360E (https=)
WO (1) WO2004113309A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104803916B (zh) 2004-11-16 2017-08-11 詹森药业有限公司 用作选择性雄激素受体调节剂(sarms)的杂环衍生物
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
CA2861066C (en) * 2012-01-12 2024-01-02 Yale University Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
CN103450112B (zh) * 2013-08-07 2019-09-13 华东理工大学 一种n-桥连接的含氮五元杂环化合物及其制备与用途
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
WO2019222272A1 (en) 2018-05-14 2019-11-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
CN113811333B (zh) 2019-05-14 2024-03-12 诺维逊生物股份有限公司 靶向抗癌核激素受体的化合物
WO2021097046A1 (en) 2019-11-13 2021-05-20 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
KR20230160299A (ko) 2021-03-23 2023-11-23 누베이션 바이오 인크. 항암 핵 호르몬 수용체 표적화 화합물
US12006314B2 (en) 2021-05-03 2024-06-11 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9602949A (es) * 1994-01-24 1997-06-28 Du Pont 2-oxa y tia-zolinas artropodicidas.
US6403623B1 (en) * 1999-05-27 2002-06-11 Unuversity Of Notre Dame Du Lac Heterocyclic antituberculosis agents
EP1401801B1 (en) * 2000-08-24 2006-11-02 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof

Also Published As

Publication number Publication date
AU2004249697A1 (en) 2004-12-29
EP1656360A1 (en) 2006-05-17
AU2004249697B2 (en) 2010-04-22
ES2291906T3 (es) 2008-03-01
DE602004008300T2 (de) 2008-05-08
PL1656360T3 (pl) 2008-01-31
PT1656360E (pt) 2007-10-22
JP2007501287A (ja) 2007-01-25
DK1656360T3 (da) 2007-12-27
EP1656360B1 (en) 2007-08-15
ATE370133T1 (de) 2007-09-15
US20050014952A1 (en) 2005-01-20
CN1835937A (zh) 2006-09-20
CA2528764A1 (en) 2004-12-29
WO2004113309A1 (en) 2004-12-29
CN1835937B (zh) 2012-07-18
JP4898446B2 (ja) 2012-03-14
DE602004008300D1 (de) 2007-09-27

Similar Documents

Publication Publication Date Title
CY1106973T1 (el) Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)
MY147985A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TW200621235A (en) Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
CY1110115T1 (el) Παραγωγα ακετυλενυλο-πυραζολο-πυριμιδινης ως mglur2 ανταγωνιστες
ATE433447T1 (de) Pyrimiidinverbindungen
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
AU2003276028A1 (en) Pyridine derivatives as cb2 receptor modulators
MA32811B1 (fr) Nouveaux composés
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
ATE449069T1 (de) Aminopropanolderivate
MXPA06003363A (es) Derivados de fenil-piperazina como moduladores de receptores muscarinicos.
MY142850A (en) Novel indole derivatives as selective androgen receptor modulators (sarms)
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
SE0300456D0 (sv) Novel compounds
CY1109371T1 (el) Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους
TW200624424A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
ATE411296T1 (de) Imidazolinderivate mit cb1-antagonistischer wirkung
TW200604171A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
TW200604170A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.